SLCO2B1 and posterior cortical atrophy: Since high expression of SLCO2B1 associated with cancer recurrence only in GS ≥ 8 patients, clinicopathological features were compared between SLCO2B1 high and low expression groups in PCa patients with GS ≥ 8 to investigate whether certain populations associated with SLCO2B1 expression (Table 2).